Long COVID essentials: link to online resources
15 October 2024. Related: On the web, COVID-19.
COVID-19
No correlation between nasal viral load and severity of COVID-19 in large vaccine studies
27 May 2024. Related: COVID-19.
Early press conference: cure, gay circumcision, PrEP choices, mpox, and COVID-19
1 August 2023. Related: Conference reports, mpox (monkeypox), HIV prevention and transmission, Cure-related research, COVID-19: HIV and COVID-19 coinfection, COVID-19.
Tenofovir reduces risk of COVID-19 in pre-vaccine studies
1 June 2023. Related: COVID-19: HIV and COVID-19 coinfection, COVID-19.
Case report of COVID-19 transmission from sneezing cat
3 August 2022. Related: Coinfections and complications, COVID-19: transmission & prevention, COVID-19.
Accumulating SARS-CoV-2 mutations in prolonged COVID-19 in advanced HIV off-ART
3 August 2022. Related: Coinfections and complications, COVID-19.
No benefit from TDF/FTC against COVID-19
3 August 2022. Related: Coinfections and complications, COVID-19: investigational drugs, COVID-19.
COVID update: new waves of BA.4 and BA.5 in the UK – all omicron variants linked to reduced antibody responses to vaccines
1 July 2022. Related: Coinfections and complications, COVID-19: vaccine research, COVID-19.
Importance of booster vaccine to protect against emergent COVID-19 variants
1 July 2022. Related: Coinfections and complications, COVID-19: vaccine research, COVID-19.
Similar COVID-19 vaccination responses in HIV positive people on ART and with good CD4 counts compared to HIV negative controls
1 July 2022. Related: Coinfections and complications, COVID-19: HIV and COVID-19 coinfection, COVID-19: vaccine research, COVID-19.
US study reports higher rates of breakthrough COVID in HIV positive vs negative controls
1 July 2022. Related: Coinfections and complications, COVID-19: HIV and COVID-19 coinfection, COVID-19: vaccine research, COVID-19.
BMJ reports UK government failed to protect doctors during COVID-19
1 July 2022. Related: Coinfections and complications, COVID-19.
Implications of SARS-CoV-2 in gut tissue for transmission of COVID-19 and long COVID
1 June 2022. Related: COVID-19.
CROI 2022: Other COVID-19 studies
2 May 2022. Related: Conference reports, Coinfections and complications, COVID-19.
Asymptomatic COVID-19 is common in people living with HIV
2 May 2022. Related: Coinfections and complications, COVID-19: HIV and COVID-19 coinfection, COVID-19.
Longest COVID-19 infection lasted 505 days in an immunocompromised person in London
2 May 2022. Related: Coinfections and complications, COVID-19: HIV and COVID-19 coinfection, COVID-19: pathogenesis, COVID-19.
Herd immunity unlikely to control COVID-19: opinion article from US NIAID
2 May 2022. Related: Coinfections and complications, COVID-19: transmission & prevention, COVID-19.
The challenges of prioritising access to molnupiravir and nirmatrelvir–ritonavir for COVID-19
2 May 2022. Related: Coinfections and complications, COVID-19: complications, COVID-19.
Increased risk of blood clots after COVID-19: higher with underlying conditions and more severe symptoms
2 May 2022. Related: Coinfections and complications, COVID-19: complications, COVID-19.
Two new platform vaccines against COVID-19 report phase 3 results
2 May 2022. Related: Coinfections and complications, Other news, COVID-19: vaccine research, COVID-19.
CROI 2022: Long COVID persists for over a year: evidence for divergent immune responses
1 April 2022. Related: Conference reports, Coinfections and complications, COVID-19: long COVID, COVID-19.
Temporary protection against omicron needs mRNA booster: limited data for those at highest risk
1 April 2022. Related: COVID-19: vaccine research, COVID-19.
Efficacy of mRNA vaccines in people with HIV or solid transplant recipients
8 March 2022. Related: COVID-19: vaccine research, COVID-19.
Long COVID may be more common in people living with HIV
1 March 2022. Related: COVID-19: HIV and COVID-19 coinfection, COVID-19.
Major review finds little benefit of remdesivir in people hospitalised with COVID-19
1 March 2022. Related: COVID-19: investigational drugs, COVID-19.
Resources on Long COVID
1 March 2022. Related: COVID-19: long COVID, COVID-19: on the web, COVID-19.
WHO webinars: COVID-19 Global Research and Innovation Forum
1 March 2022. Related: COVID-19: on the web, COVID-19.
UK RECOVERY study shows no benefit from aspirin in people hospitalised with COVID-19
7 February 2022. Related: COVID-19: investigational drugs, COVID-19.
IDSA update COVID-19 guidelines (January 2022)
7 February 2022. Related: COVID-19: guidelines, COVID-19.
Reducing the risk of COVID-19 in research that involves interrupting ART
20 December 2021. Related: Cure-related research, COVID-19.
New BHIVA statements on HIV and COVID-19 (December 2021)
20 December 2021. Related: COVID-19: HIV and COVID-19 coinfection, COVID-19.
Myocarditis and pericarditis after COVID-19 vaccines
20 December 2021. Related: COVID-19: vaccine research, COVID-19.
WHO advises against use of convalescent plasma for COVID-19
20 December 2021. Related: COVID-19: investigational drugs, COVID-19.
Colchicine: no clinical benefits against COVID-19 in pooled analysis of RCTs
30 November 2021. Related: COVID-19: investigational drugs, COVID-19.
Eli Lilly withdraw EU application for bNAbs etesevimab and bamlanivimab
30 November 2021. Related: COVID-19: investigational drugs, COVID-19.
Reduced responses to COVID-19 vaccines at low CD4 counts
31 October 2021. Related: Conference reports, COVID-19: HIV and COVID-19 coinfection, COVID-19.
Continued evidence for poorer COVID-19 outcomes in people with HIV
31 October 2021. Related: COVID-19: HIV and COVID-19 coinfection, COVID-19.
Immune responses to natural COVID-19 infection in HIV positive people
31 October 2021. Related: COVID-19: HIV and COVID-19 coinfection, COVID-19.
Durability of immune responses to COVID-19 vaccines in HIV positive people
31 October 2021. Related: COVID-19: vaccine research, COVID-19.
Sputnik V vaccine not approved in South Africa due to potential increased risk of HIV
31 October 2021. Related: COVID-19: vaccine research, COVID-19.
Sanofi reports phase 1/2 mRNA results but withdraws from further COVID19 vaccines
31 October 2021. Related: COVID-19: vaccine research, COVID-19.
Early efficacy results with oral molnupiravir focuses attention on price and access
31 October 2021. Related: COVID-19: treatment access, COVID-19: investigational drugs, COVID-19.
BHIVA statements on third vaccine doses for people living with HIV
17 September 2021. Related: COVID-19: HIV and COVID-19 coinfection, COVID-19: vaccine research, COVID-19.
HIV increases risk of severe COVID-19 in largest US study
17 September 2021. Related: COVID-19: HIV and COVID-19 coinfection, COVID-19.
SARS-CoV-2 variants and immunosuppression
17 September 2021. Related: COVID-19: HIV and COVID-19 coinfection, COVID-19.
UK vaccine programme saved 100,000 lives
17 September 2021. Related: COVID-19: vaccine research, COVID-19.
Large US registry confirms safety of COVID-19 vaccines during pregnancy
17 September 2021. Related: COVID-19: vaccine research, COVID-19.
US FDA grants full approval to Pfizer vaccine
17 September 2021. Related: COVID-19: vaccine research, COVID-19.
Immune responses against Delta variant in people vaccinated in the UK
17 September 2021. Related: COVID-19: vaccine research, COVID-19.
Neutralising antibody levels from COVID vaccines correlate negatively with age
17 September 2021. Related: COVID-19: vaccine research, COVID-19.
Evolution of neutralising antibody responses to natural infection and after vaccination
17 September 2021. Related: COVID-19: vaccine research, COVID-19.
Outbreak of 469 symptomatic Delta cases in fully vaccinated adults during Bear Week
17 September 2021. Related: COVID-19: transmission & prevention, COVID-19.
IAS 2021: WHO report links HIV to 30% increased mortality from COVID-19: based on South African data
1 August 2021. Related: Conference reports, COVID-19: HIV and COVID-19 coinfection, COVID-19.
Antibody responses to Pfizer vaccine in HIV positive people with high CD4 counts
1 August 2021. Related: COVID-19: HIV and COVID-19 coinfection, COVID-19: vaccine research, COVID-19.
Third dose of mRNA vaccine improves antibody responses in kidney transplant recipients
1 August 2021. Related: COVID-19: vaccine research, COVID-19.
US CDC recommends third vaccine dose in some groups
1 August 2021. Related: COVID-19: vaccine research, COVID-19.
Pfizer plans for third dose: questions over population need?
1 August 2021. Related: COVID-19: vaccine research, COVID-19.
Efficacy of Oxford/AZ and Pfizer vaccines against Delta variant in the UK
1 August 2021. Related: COVID-19: vaccine research, COVID-19.
Results from Novavax phase 3 study in the UK
1 August 2021. Related: COVID-19: vaccine research, COVID-19.
WHO approves Chinese vaccines for emergency use
1 August 2021. Related: COVID-19: vaccine research, COVID-19.
Selected other vaccine studies
1 August 2021. Related: COVID-19: vaccine research, COVID-19.
Efficacy of Chinese CoronaVac vaccine in Chile national programme
1 August 2021. Related: COVID-19: vaccine research, COVID-19.
NHS supports selected use of inhaled budesonide for COVID-19 in people at risk of severe events
1 August 2021. Related: COVID-19: investigational drugs, COVID-19.
Reviews of ivermectin for COVID-19: no evidence of benefit from RCTs
1 August 2021. Related: COVID-19: investigational drugs, COVID-19.
RCT shows no impact of azithromycin in reducing symptoms of mild COVID-19
1 August 2021. Related: COVID-19: investigational drugs, COVID-19.